Consensus recommendations on standardized magnetic resonance imaging protocols for multicenter canine brain tumor clinical trials
暂无分享,去创建一个
Christina Mazcko | Michael S Kent | Rebecca A Packer | J. Griffin | J. Rossmeisl | C. Mazcko | A. LeBlanc | R. Packer | M. Kent | John H Rossmeisl | John F Griffin | Amy K LeBlanc
[1] J. Cairncross,et al. Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Yong-li Li,et al. Comparison of volumetric methods for tumor measurements on two and three dimensional MRI in adult glioblastoma , 2011, Neuroradiology.
[3] P. Choyke,et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.
[4] J. Edwards,et al. Seizure-induced brain lesions: a wide spectrum of variably reversible MRI abnormalities. , 2013, European journal of radiology.
[5] Susan M. Chang,et al. Response Assessment in Neuro-Oncology Clinical Trials. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] G. Beauchamp,et al. Effect of acquisition time and chemical fat suppression on meningeal enhancement on MR imaging in dogs. , 2012, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[7] D. Brachman,et al. Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. , 2016, Neuro-oncology.
[8] Wenzhen Zhu,et al. Comparative study of 3D-SPGR vs 2D-SE T1WI after enhancement in the brain. , 2003, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
[9] C. Kuhl,et al. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience. , 2005, Radiology.
[10] F. Bova,et al. Frameless stereotactic radiosurgery for the treatment of primary intracranial tumours in dogs. , 2015, Veterinary and comparative oncology.
[11] E. Melhem,et al. Dynamic T1‐weighted spin‐echo MR imaging: The role of digital subtraction in the demonstration of enhancing brain lesions , 1999, Journal of magnetic resonance imaging : JMRI.
[12] K. E. Chow,et al. EARLY POSTOPERATIVE MAGNETIC RESONANCE IMAGING FINDINGS IN FIVE DOGS WITH CONFIRMED AND SUSPECTED BRAIN TUMORS. , 2015, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[13] Patrick Y Wen,et al. Application of Novel Response/Progression Measures for Surgically Delivered Therapies for Gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group , 2012, Neurosurgery.
[14] K Sartor,et al. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. , 1994, Neurosurgery.
[15] E. Riedesel,et al. Normal canine brain maturation at magnetic resonance imaging. , 2010, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[16] C. Glaser,et al. Understanding 3D TSE Sequences: Advantages, Disadvantages, and Application in MSK Imaging , 2015, Seminars in Musculoskeletal Radiology.
[17] J. Griffin,et al. Comparison of two fat-suppressed magnetic resonance imaging pulse sequences to standard t2-weighted images for brain parenchymal contrast and lesion detection in dogs with inflammatory intracranial disease. , 2015, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[18] F. Ståhlberg,et al. Brain lesion contrast in MR imaging , 1997, Acta radiologica.
[19] A. Omuro,et al. Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence , 2015, American Journal of Neuroradiology.
[20] C. Matula,et al. Magnetic Resonance Imaging Contrast Enhancement of Brain Tumors at 3 Tesla Versus 1.5 Tesla , 2002, Investigative radiology.
[21] B. Meij,et al. Hypophysectomy as a treatment for canine and feline Cushing's disease. , 2001, The Veterinary clinics of North America. Small animal practice.
[22] C. Jack,et al. Alzheimer's Disease Neuroimaging Initiative , 2008 .
[23] M. Podell,et al. International Veterinary Epilepsy Task Force recommendations for a veterinary epilepsy-specific MRI protocol , 2015, BMC Veterinary Research.
[24] D. Scoffings,et al. Imaging of the post-operative cranium. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.
[25] R. Ruthazer,et al. Magnetic resonance imaging apparent diffusion coefficients for histologically confirmed intracranial lesions in dogs. , 2011, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[26] E. Hattingen,et al. Time window for postoperative reactive enhancement after resection of brain tumors: less than 72 hours. , 2014, Neurosurgical focus.
[27] P. Dickinson. Advances in Diagnostic and Treatment Modalities for Intracranial Tumors , 2014, Journal of veterinary internal medicine.
[28] P. Wen,et al. Response Assessment in Neuro-Oncology , 2011, Current oncology reports.
[29] K Farahani,et al. Effect of field strength on susceptibility artifacts in magnetic resonance imaging. , 1990, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.
[30] J. Lee,et al. Improved motion-sensitized driven-equilibrium preparation for 3D turbo spin echo T1 weighted imaging after gadolinium administration for the detection of brain metastases on 3T MRI. , 2016, The British journal of radiology.
[31] M. Berger,et al. Canine spontaneous glioma: a translational model system for convection-enhanced delivery. , 2010, Neuro-oncology.
[32] R. M. Simpson,et al. Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients. , 2016, Neuro-oncology.
[33] John H. Sampson,et al. A Novel Method for Volumetric MRI Response Assessment of Enhancing Brain Tumors , 2011, PloS one.
[34] B. Meij,et al. The Influence of Pituitary Size on Outcome After Transsphenoidal Hypophysectomy in a Large Cohort of Dogs with Pituitary‐Dependent Hypercortisolism , 2016, Journal of veterinary internal medicine.
[35] Zhu Wenzhen,et al. Comparative study of 3D-SPGR vs 2D-SE T1WI after enhancement in the brain , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].
[36] Naoya Hashimoto,et al. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. , 2015, The Lancet. Oncology.
[37] M. Roos,et al. Irradiation of brain tumors in dogs with neurologic disease. , 2005, Journal of veterinary internal medicine.
[38] I. Polis,et al. Comparison between symptomatic treatment and lomustine supplementation in 71 dogs with intracranial, space-occupying lesions. , 2014, Veterinary and comparative oncology.
[39] E. Merkle,et al. A review of MR physics: 3T versus 1.5T. , 2007, Magnetic resonance imaging clinics of North America.
[40] Kenneth R. Maravilla,et al. Distinction between glioma progression and post-radiation change by combined physiologic MR imaging , 2010, Neuroradiology.
[41] M. Kent,et al. Treatment of MRI‐Diagnosed Trigeminal Peripheral Nerve Sheath Tumors by Stereotactic Radiotherapy in Dogs , 2016, Journal of veterinary internal medicine.
[42] A Gregory Sorensen,et al. Emerging techniques and technologies in brain tumor imaging. , 2014, Neuro-oncology.
[43] M. Kent,et al. Perfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and Radiotherapy , 2016, Journal of veterinary internal medicine.
[44] N. Jeffery,et al. Systematic Review of Brain Tumor Treatment in Dogs , 2015, Journal of veterinary internal medicine.
[45] S. Schatzberg,et al. Magnetic resonance imaging for the differentiation of neoplastic, inflammatory, and cerebrovascular brain disease in dogs. , 2012, Journal of veterinary internal medicine.
[46] T. Cascino,et al. Response criteria for phase II studies of supratentorial malignant glioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[48] Veterinary cooperative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1. , 2016, Veterinary and comparative oncology.
[49] S. Hecht,et al. Use of the T2*-weighted gradient recalled echo sequence for magnetic resonance imaging of the canine and feline brain. , 2014, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[50] M. C. Han,et al. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T. , 1994, AJNR. American journal of neuroradiology.
[51] M. Okada,et al. [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. , 2009, Gan to kagaku ryoho. Cancer & chemotherapy.
[52] S. Schatzberg,et al. Evaluation of standard magnetic resonance characteristics used to differentiate neoplastic, inflammatory, and vascular brain lesions in dogs. , 2014, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[53] S. Stuckey,et al. Transient Seizure‐Related MRI Abnormalities , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[54] Siegfried Trattnig,et al. Effect of Contrast Dose and Field Strength in the Magnetic Resonance Detection of Brain Metastases , 2003, Investigative radiology.
[55] Marion Smits,et al. Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. , 2015, Neuro-oncology.
[56] R. Packer,et al. Magnetic Resonance Imaging Appearance and Mechanism of Action of Five Hemostatic Agents Used in Neurosurgery. , 2016, Veterinary surgery : VS.
[57] Mark Dewhirst,et al. Perspectives from man’s best friend: National Academy of Medicine’s Workshop on Comparative Oncology , 2016, Science Translational Medicine.
[58] N. Jeffery,et al. Findings on low-field cranial MR images in epileptic dogs that lack interictal neurological deficits. , 2008, Veterinary journal.
[59] Debiao Li,et al. Whole‐brain intracranial vessel wall imaging at 3 Tesla using cerebrospinal fluid–attenuated T1‐weighted 3D turbo spin echo , 2017, Magnetic resonance in medicine.
[60] Martin Bendszus,et al. Response assessment criteria for brain metastases: proposal from the RANO group. , 2015, The Lancet. Oncology.
[61] Anwar R. Padhani,et al. Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy , 2010, Targeted Oncology.
[62] M. Shiroishi,et al. Brain tumors: a multimodality approach with diffusion-weighted imaging, diffusion tensor imaging, magnetic resonance spectroscopy, dynamic susceptibility contrast and dynamic contrast-enhanced magnetic resonance imaging. , 2013, Magnetic resonance imaging clinics of North America.
[63] Michael W. Weiner,et al. Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014 , 2015, Alzheimer's & Dementia.
[64] D. Thamm,et al. Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document. , 2015, Veterinary and comparative oncology.
[65] T. Chenevert,et al. Diffusion-weighted MRI for assessment of early cancer treatment response. , 2010, Current pharmaceutical biotechnology.
[66] P. Morgan,et al. Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas , 2016, American Journal of Neuroradiology.
[67] Gary Kelloff,et al. The Quantitative Imaging Network: NCI's Historical Perspective and Planned Goals. , 2014, Translational oncology.
[68] B. Erickson,et al. Optimal Presentation Modes for Detecting Brain Tumor Progression , 2011, American Journal of Neuroradiology.
[69] Dima Suki,et al. Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. , 2016, JAMA oncology.
[70] C. Khanna,et al. Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document. , 2010, Veterinary and comparative oncology.
[71] L Junck,et al. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. , 2011, The Lancet. Oncology.
[72] N. Rofsky,et al. Image subtraction in gadolinium-enhanced MR imaging. , 1996, AJR. American journal of roentgenology.
[73] C. Khanna,et al. Defining the Value of a Comparative Approach to Cancer Drug Development , 2015, Clinical Cancer Research.
[74] Eudocia Q Lee,et al. Assessment of Brain Tumor Response: RANO and Its Offspring , 2016, Current Treatment Options in Oncology.
[75] P. Dickinson,et al. Reversible magnetic resonance imaging abnormalities in dogs following seizures. , 1999, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[76] Andrew D. Miller,et al. Characteristics and Survival of 121 Cats Undergoing Excision of Intracranial Meningiomas (1994-2011). , 2015, Veterinary surgery : VS.
[77] Thomas L Ellis,et al. Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas. , 2015, Journal of neurosurgery.
[78] M. Khan,et al. The recurrence of intracranial meningiomas after surgical treatment. , 1983, Journal of neurosurgery.
[79] Susan M. Chang,et al. Endpoints for clinical trials and revised assessment in neuro-oncology. , 2012, Current opinion in neurology.
[80] Mitsuru Ikeda,et al. Contrast-enhanced MR imaging of metastatic brain tumor at 3 tesla: utility of T(1)-weighted SPACE compared with 2D spin echo and 3D gradient echo sequence. , 2008, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[81] M. Christian,et al. [New guidelines to evaluate the response to treatment in solid tumors]. , 2000, Bulletin du cancer.
[82] S. Frean,et al. Appearance of the canine meninges in subtraction magnetic resonance images. , 2014, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[83] J. Uhm. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group , 2010 .
[84] Diffusion-weighted magnetic resonance imaging of the normal canine brain. , 2014, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[85] M. Sullivan,et al. Effect of delayed acquisition times on gadolinium-enhanced magnetic resonance imaging of the presumably normal canine brain. , 2011, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[86] S. Schatzberg,et al. Magnetic resonance imaging features of intracranial astrocytomas and oligodendrogliomas in dogs. , 2011, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[87] K. Togashi,et al. T1-weighted MR imaging of glioma at 3T: a comparative study of 3D MPRAGE vs. conventional 2D spin-echo imaging. , 2016, Clinical imaging.
[88] R. Dodge,et al. Analysis of survival in a retrospective study of 86 dogs with brain tumors. , 1991, Journal of veterinary internal medicine.
[89] J. Henson,et al. Brain Tumor Imaging in Clinical Trials , 2008, American Journal of Neuroradiology.
[90] Charles A. Gooding,et al. Computed tomography and magnetic resonance imaging , 1990 .
[91] John H. Sampson,et al. A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma. , 2014, Journal of neurosurgery.
[92] Paulo A. Garcia,et al. Invited review--neuroimaging response assessment criteria for brain tumors in veterinary patients. , 2014, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[93] Dongsheng Duan,et al. A One Health overview, facilitating advances in comparative medicine and translational research , 2016, Clinical and Translational Medicine.